Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice (original) (raw)

• Kaplan RN, Psaila B, Lyden D (2006) Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond. Cancer Metastasis Rev 25(4):521–529
  Article PubMed Google Scholar
• Ahn GO, Brown JM (2008) Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 13(3):193–205
  Article PubMed CAS Google Scholar
• Seandel M, Butler J, Lyden D, Rafii S (2008) A catalytic role for proangiogenic marrow-derived cells in tumor neovascularization. Cancer Cell 13(3):181–183
  Article PubMed CAS Google Scholar
• Fricke I, Mirza N, Dupont J, Lockhart C, Jackson A, Lee JH et al (2007) Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses. Clin Cancer Res 13(16):4840–4848
  Article PubMed CAS Google Scholar
• Serafini P, Meckel K, Kelso M, Noonan K, Califano J, Koch W et al (2006) Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. J Exp Med 203(12):2691–2702
  Article PubMed CAS Google Scholar
• Serafini P, Mgebroff S, Noonan K, Borrello I (2008) Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res 68(13):5439–5449
  Article PubMed CAS Google Scholar
• Melani C, Chiodoni C, Forni G, Colombo MP (2003) Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 102(6):2138–2145
  Article PubMed CAS Google Scholar
• Bronte V, Serafini P, Apolloni E, Zanovello P (2001) Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J Immunother 24(6):431–446
  Article PubMed CAS Google Scholar
• Grizzle WE, Xu X, Zhang S, Stockard CR, Liu C, Yu S et al (2007) Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice. Mech Ageing Dev 128(11–12):672–680
  Article PubMed CAS Google Scholar
• Talmadge JE (2007) Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy. Clin Cancer Res 13(18 Pt 1):5243–5248
  Article PubMed CAS Google Scholar
• Gabrilovich D (2004) Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 4(12):941–952
  Article PubMed CAS Google Scholar
• Badger AM, King AG, Talmadge JE, Schwartz DA, Picker DH, Mirabelli CK et al (1990) Induction of non-specific suppressor cells in normal Lewis rats by a novel azaspirane SK&F 105685. J Autoimmun 3(4):485–500
  Article PubMed CAS Google Scholar
• Holda JH, Maier T, Claman HN (1985) Murine graft-versus-host disease across minor barriers: immunosuppressive aspects of natural suppressor cells. Immunol Rev 88:87–105
  Article PubMed CAS Google Scholar
• Strober S (1984) Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. Annu Rev Immunol 2:219–237
  Article PubMed CAS Google Scholar
• Bronte V, Apolloni E, Cabrelle A, Ronca R, Serafini P, Zamboni P et al (2000) Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 96(12):3838–3846
  PubMed CAS Google Scholar
• Bronte V, Wang M, Overwijk WW, Surman DR, Pericle F, Rosenberg SA et al (1998) Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. J Immunol 161(10):5313–5320
  PubMed CAS Google Scholar
• Leenen PJ, de Bruijn MF, Voerman JS, Campbell PA, van EW (1994) Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods 174(1–2):5–19
  Article PubMed CAS Google Scholar
• Gallina G, Dolcetti L, Serafini P, De SC, Marigo I, Colombo MP et al (2006) Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 116(10):2777–2790
  Article PubMed CAS Google Scholar
• Huang B, Pan PY, Li Q, Sato AI, Levy DE, Bromberg J et al (2006) Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 66(2):1123–1131
  Article PubMed CAS Google Scholar
• Dugast AS, Haudebourg T, Coulon F, Heslan M, Haspot F, Poirier N et al (2008) Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol 180(12):7898–7906
  PubMed CAS Google Scholar
• Rodriguez PC, Ochoa AC (2008) Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev 222:180–191
  Article PubMed CAS Google Scholar
• Serafini P, De Santo C, Marigo I, Cingarlini S, Dolcetti L, Gallina G et al (2004) Derangement of immune responses by myeloid suppressor cells. Cancer Immunol Immunother 53(2):64–72
  Article PubMed CAS Google Scholar
• Donkor M, Lahue E, Hoke T, Shafer L, Coskun U, Solheim JC et al. (2009) Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. Int Immunopharmacol. [Epub ahead of print]
• Talmadge JE, Singh RK, Fidler IJ, Raz A (2007) Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 170(3):793–804
  Article PubMed CAS Google Scholar
• Talmadge JE, Hood KC, Zobel LC, Shafer LR, Coles M, Toth B (2007) Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion. Int Immunopharmacol 7(2):140–151
  Article PubMed CAS Google Scholar
• Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408
  Article PubMed CAS Google Scholar
• Guy CT, Cardiff RD, Muller WJ (1996) Activated neu induces rapid tumor progression. J Biol Chem 271(13):7673–7678
  Article PubMed CAS Google Scholar
• Key ME, Talmadge JE, Fogler WE, Bucana C, Fidler IJ (1982) Isolation of tumoricidal macrophages from lung melanoma metastases of mice treated systemically with liposomes containing a lipophilic derivative of muramyl dipeptide. J Natl Cancer Inst 69(5):1198
  PubMed CAS Google Scholar
• Shojaei F, Wu X, Malik AK, Zhong C, Baldwin ME, Schanz S et al (2007) Tumor refractoriness to anti-VEGF treatment is mediated by CD11b + Gr1 + myeloid cells. Nat Biotechnol 25(8):911–920
  Article PubMed CAS Google Scholar
• Salomon DS, Brandt R, Ciardiello F, Normanno N (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19(3):183–232
  Article PubMed CAS Google Scholar
• Bouchard L, Lamarre L, Tremblay PJ, Jolicoeur P (1989) Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57(6):931–936
  Article PubMed CAS Google Scholar
• Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ (1992) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89(22):10578–10582
  Article PubMed CAS Google Scholar
• Wellings SR, Jensen HM (1973) On the origin and progression of ductal carcinoma in the human breast. J Natl Cancer Inst 50(5):1111–1118
  PubMed CAS Google Scholar
• Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54(1):105–115
  Article PubMed CAS Google Scholar
• Di CE, Diodoro MG, Boggio K, Modesti A, Modesti M, Nanni P et al (1999) Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. Lab Invest 79(10):1261–1269
  Google Scholar
• Boggio K, Nicoletti G, Di Carlo E, Cavallo F, Landuzzi L, Melani C et al (1998) Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med 188(3):589–596
  Article PubMed CAS Google Scholar
• Nanni P, Nicoletti G, De GC, Landuzzi L, Di CE, Iezzi M et al (2003) Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12. Int J Cancer 105(3):384–389
  Article PubMed CAS Google Scholar
• Sas S, Chan T, Sami A, El-Gayed A, Xiang J (2008) Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice. Cancer Gene Ther 15(10):655–666
  Article PubMed CAS Google Scholar
• Singh R, Paterson Y (2006) Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer. Cancer Res 66(15):7748–7757
  Article PubMed CAS Google Scholar
• Boggio K, Di CE, Rovero S, Cavallo F, Quaglino E, Lollini PL et al (2000) Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. Cancer Res 60(2):359–364
  PubMed CAS Google Scholar
• Cipriani B, Fridman A, Bendtsen C, Dharmapuri S, Mennuni C, Pak I et al (2008) Therapeutic vaccination halts disease progression in BALB-neuT mice: the amplitude of elicited immune response is predictive of vaccine efficacy. Hum Gene Ther 19(7):670–680
  Article PubMed CAS Google Scholar
• Street SE, Zerafa N, Iezzi M, Westwood JA, Stagg J, Musiani P et al (2007) Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma. Cancer Res 67(11):5454–5460
  Article PubMed CAS Google Scholar
• Henry MD, Triplett AA, Oh KB, Smith GH, Wagner KU (2004) Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Oncogene 23(41):6980–6985
  Article PubMed CAS Google Scholar
• Landis MD, Seachrist DD, Abdul-Karim FW, Keri RA (2006) Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors. Oncogene 25(23):3325–3334
  Article PubMed CAS Google Scholar
• Estrov Z, Talpaz M, Mavligit G, Pazdur R, Harris D, Greenberg SM et al (1995) Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis. Am J Med 98(6):551–558
  Article PubMed CAS Google Scholar
• Kitamura H, Kodama F, Odagiri S, Nagahara N, Inoue T, Kanisawa M (1989) Granulocytosis associated with malignant neoplasms: a clinicopathologic study and demonstration of colony-stimulating activity in tumor extracts. Hum Pathol 20(9):878–885
  Article PubMed CAS Google Scholar
• Ruka W, Rutkowski P, Kaminska J, Rysinska A, Steffen J (2001) Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance. Ann Oncol 12(10):1423–1432
  Article PubMed CAS Google Scholar
• Fu YX, Watson G, Jimenez JJ, Wang Y, Lopez DM (1990) Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Cancer Res 50(2):227–234
  PubMed CAS Google Scholar
• Pan PY, Wang GX, Yin B, Ozao J, Ku T, Divino CM et al (2008) Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. Blood 111(1):219–228
  Article PubMed CAS Google Scholar
• Bronte V, Chappell DB, Apolloni E, Cabrelle A, Wang M, Hwu P et al (1999) Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. J Immunol 162(10):5728–5737
  PubMed CAS Google Scholar
• Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S et al (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2(10):1096–1103
  Article PubMed CAS Google Scholar
• Oyama T, Ran S, Ishida T, Nadaf S, Kerr L, Carbone DP et al (1998) Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J Immunol 160(3):1224–1232
  PubMed CAS Google Scholar
• Young MR, Kolesiak K, Wright MA, Gabrilovich DI (1999) Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor. Clin Exp Metastasis 17(10):881–888
  Article PubMed CAS Google Scholar
• Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ (2009) Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy. Cancer Immunol Immunother 58(1):49–59
  Article PubMed CAS Google Scholar
• Ochoa AC, Zea AH, Hernandez C, Rodriguez PC (2007) Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 13(2 Pt 2):721s–726s
  Article PubMed CAS Google Scholar
• Marty M, Pivot X (2008) The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab. Eur J Cancer 44(7):912–920
  Article PubMed CAS Google Scholar
• Krishnamurthy S, Sneige N (2002) Molecular and biologic markers of premalignant lesions of human breast. Adv Anat Pathol 9(3):185–197
  Article PubMed Google Scholar
• Melani C, Sangaletti S, Barazzetta FM, Werb Z, Colombo MP (2007) Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. Cancer Res 67(23):11438–11446
  Article PubMed CAS Google Scholar
• Gabrilovich DI, Bronte V, Chen SH, Colombo MP, Ochoa A, Ostrand-Rosenberg S et al (2007) The terminology issue for myeloid-derived suppressor cells. Cancer Res 67(1):425
  Article PubMed CAS Google Scholar
• Kusmartsev S, Gabrilovich DI (2002) Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol Immunother 51(6):293–298
  Article PubMed CAS Google Scholar
• Solheim JC, Reber AJ, Ashour AE, Robinson S, Futakuchi M, Kurz SG et al (2007) Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injection. Cancer Gene Ther 14(4):364–371
  Article PubMed CAS Google Scholar
• Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM (2001) Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J Immunol 166(9):5398–5406
  PubMed CAS Google Scholar
• Kusmartsev S, Eruslanov E, Kubler H, Tseng T, Sakai Y, Su Z et al (2008) Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma. J Immunol 181(1):346–353
  PubMed CAS Google Scholar
• Reilly RT, Gottlieb MB, Ercolini AM, Machiels JP, Kane CE, Okoye FI et al (2000) HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice. Cancer Res 60(13):3569–3576
  PubMed CAS Google Scholar
• Serafini P, Carbley R, Noonan KA, Tan G, Bronte V, Borrello I (2004) High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res 64(17):6337–6343
  Article PubMed CAS Google Scholar
• Parmiani G, Castelli C, Pilla L, Santinami M, Colombo MP, Rivoltini L (2007) Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients. Ann Oncol 18(2):226–232
  Article PubMed CAS Google Scholar
• Reber AJ, Ashour AE, Robinson SN, Talmadge JE, Solheim JC (2004) Flt3 ligand bioactivity and pharmacology in neoplasia. Curr Drug Targets Immune Endocr Metabol Disord 4(2):149–156
  Article PubMed CAS Google Scholar
• Calogero RA, Cordero F, Forni G, Cavallo F (2007) Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice. Breast Cancer Res 9(4):211
  Article PubMed CAS Google Scholar
• Worschech A, Kmieciak M, Knutson KL, Bear HD, Szalay AA, Wang E et al (2008) Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors. Cancer Res 68(7):2436–2446
  Article PubMed CAS Google Scholar
• Astolfi A, Landuzzi L, Nicoletti G, De GC, Croci S, Palladini A et al (2005) Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. Am J Pathol 166(4):1205–1216
  PubMed CAS Google Scholar